Myalept 11.3 mg/2.2mL
metreleptin · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Chiesi USA, Inc.
Myalept is a injection, powder, lyophilized, for solution containing metreleptin at 11.3 mg/2.2mL, taken subcutaneous. Manufactured by Chiesi USA, Inc..
Key Facts
- Brand Name
- Myalept
- Generic Name
- metreleptin
- NDC Code (Product)
10122-210- Manufacturer
- Chiesi USA, Inc.
- Strength
- 11.3 mg/2.2mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA125390
- Drug Class
- Leptin Analog [EPC]
- Marketing Start
- 03/05/2015
Recall History
No Recall HistoryFrequently Asked Questions
What is Myalept used for?
Myalept contains metreleptin. It is a injection, powder, lyophilized, for solution taken subcutaneous. Consult your doctor for specific uses.
Is Myalept a controlled substance?
Myalept is not classified as a controlled substance by the DEA.
What is the generic name for Myalept?
The generic name for Myalept is metreleptin. There are no other listed brand versions of metreleptin.
What is the NDC code for Myalept 11.3 mg/2.2mL?
The NDC (National Drug Code) for Myalept 11.3 mg/2.2mL is 10122-210, listed by Chiesi USA, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)